Science Explorer Back to mapMap
Discussion
Researcher · The University of Texas MD Anderson Cancer Center · United States

Hagop M. Kantarjian

Hagop M. Kantarjian publishes mostly in Hematology, Genetics and Molecular Biology, on topics such as Acute Myeloid Leukemia Research, Chronic Lymphocytic Leukemia Research and Chronic Myeloid Leukemia Treatments.

OpenAlex
World rank
#613,229
of 7,710,434 ranked researchers
Rank in United States
#209,968
of 1,627,098
Works
233
Citations
5.7k
Citations per work
24.6
h-index
35
i10-index 68Top 8.5% in Hematology
Hagop M. Kantarjian

What does Hagop M. Kantarjian research?

Hagop M. Kantarjian's work is mostly in Medicine (72%), Biochemistry, Genetics and Molecular Biology (8%).

Health Sciences: 169 works · 72.4% of their workMedicine: 169 works · 72.4% of their workHematology: 82 works · 35.3% of their workGenetics: 48 works · 20.6% of their workPublic Health, Environmental and Occupational Health: 17 works · 7.4% of their workOncology: 14 works · 5.8% of their workPathology and Forensic Medicine: 8 works · 3.3% of their workEverything else: 45 works · 19.4% of their workLife Sciences: 19 works · 8.2% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 8.2% of their workMolecular Biology: 19 works · 8.2% of their workTHEIR WORKHagop M.Kantarjian233works
Life Sciences8%Health Sciences72%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine16972.4%
  2. Everything else4519.4%
    1. Biochemistry, Genetics and Molecular Biology198.2%
  1. 1Hematology35% of their works
  2. 2Genetics21% of their works
  3. 3Molecular Biology8% of their works
  4. 4Public Health, Environmental and Occupational Health7% of their works
  5. 5Oncology6% of their works
  6. 6Pathology and Forensic Medicine3% of their works

Research topics

Which keywords describe Hagop M. Kantarjian's research?

The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Chronic Lymphocytic Leukemia, Genomic Aberrations, BCR-ABL and Imatinib.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Prognostic Factors2503 topics
  2. AML1171 topic
  3. Acute Myeloid Leukemia1171 topic
  4. Rituximab1062 topics
  5. Chronic Lymphocytic Leukemia861 topic
  6. Genomic Aberrations861 topic
  7. BCR-ABL811 topic
  8. Imatinib811 topic
  9. Minimal Residual Disease642 topics
  10. Acute Lymphoblastic Leukemia471 topic
  11. Childhood Cancer471 topic
  12. JAK2 Mutation371 topic
  13. Myelofibrosis371 topic
  14. Classification342 topics
  15. Lymphoma201 topic
  16. Molecular Profiling201 topic
  17. Diagnosis Criteria171 topic
  18. International Myeloma Working Group171 topic
  19. Fusion Genes141 topic
  20. Hypereosinophilic Syndrome141 topic

Where does Hagop M. Kantarjian work?

Hagop M. Kantarjian's main affiliation in the publication record is The University of Texas MD Anderson Cancer Center, United States.

How many publications and citations does Hagop M. Kantarjian have?

OpenAlex counts 233 works and 5,726 citations for Hagop M. Kantarjian, an h-index of 35, ranking #613,229 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Hagop M. Kantarjian

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Hagop M. Kantarjian. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.